ojrdrtОнкологический журнал: лучевая диагностика, лучевая терапияJournal of oncology: diagnostic radiology and radiotherapy2587-75932713-167XНЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»10.37174/2587-7593-2019-2-1-51-65ojrdrt-19Research ArticleКОМБИНИРОВАННЫЕ МЕТОДЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯCOMBINED METHODS OF DIAGNOSTICS AND TREATMENTКомплексная лабораторно-инструментальная диагностика опухолей яичниковThe Laboratory and Instrumental Complex in the Ovarian Lesions DiagnosisОлимовБ. П.OlimovB. P.

Москва

Moscow

AlimovBP90@gmail.comКоссовФ. А.KossovF. A.

Москва

Moscow

ОгрельцоваО. Н.StreltsovaO. N.

Москва

ПаниченкоИ. В.PanichenkoI. V.

Москва

ПановВ. О.PanovV. O.

Москва

Moscow

ДолгушинБ. И.DolgushinB. I.

Москва

Moscow

ТюринИ. Е.TyurinI. E.

Москва

Moscow

Российская медицинская академия непрерывного профессионального образования Минздрава РоссииРоссияRussian Medical Academy of Continuous Postgraduate EducationRussian FederationНациональный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава РФРоссияN.N. Blokhin National Medical Research Center of OncologyRussian FederationРоссийская медицинская академия непрерывного профессионального образования Минздрава России; Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава РФРоссияRussian Medical Academy of Continuous Postgraduate Education; N.N. Blokhin National Medical Research Center of OncologyRussian Federation201930032019215165Copyright © Олимов Б.П., Коссов Ф.А., Огрельцова О.Н., Паниченко И.В., Панов В.О., Долгушин Б.И., Тюрин И.Е., 20192019Олимов Б.П., Коссов Ф.А., Огрельцова О.Н., Паниченко И.В., Панов В.О., Долгушин Б.И., Тюрин И.Е.Olimov B.P., Kossov F.A., Streltsova O.N., Panichenko I.V., Panov V.O., Dolgushin B.I., Tyurin I.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncoradjournal.ru/jour/article/view/19

Опухоли яичников являются наиболее частыми в структуре онкологической заболеваемости у женщин. Ежегодно в мире регистрируются более 239 тыс. новых наблюдений и более 152 тыс. умирают от злокачественных опухолей яичников. Диагностика опухолей яичников на ранних стадиях затруднительна из-за отсутствия надежных специфических тестов, позволяющих выявить заболевание на начальных этапах его развития. Представлен аналитический обзор литературных данных, касающихся первичной лабораторно-инструментальной диагностики опухолей яичников, рассмотрена их роль в диагностике и лечении пациентов со злокачественным заболеванием яичников.

Ovarian cancer is the most frequent oncological disease in women. Annually more than 239 000 new cases are registered and more than 152 000 women die from this malignant tumor. Diagnosis of an early ovarian cancer is difficult because of the lack specific methods, which can help to detect tumors in early stages. In this article we analyzed the literate data according to the primary laboratory and instrumental methods of diagnosis, their role in diagnostics and treatment of patients with ovarian cancer.

опухоли яичниковмагнитно-резонансная томографиядиффузионно-взвешенная томографиядинамическая МРТ с контрастным усилениемСА-125ультразвуковые исследованияКТмультимодальная визуализацияovarian lesionsmagnetic resonance imagingdiffusion-weighted imagingdynamic MRI with contrast enhancementCA-125ultrasoundCTmultimodal imagingReferencesFerlay J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 // Int. J. Cancer. 2015. Vol. 136. P. 359-386.Ferlay J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 // Int. J. Cancer. 2015. Vol. 136. P. 359-386.Wanqing Chen et al. Cancer statistics in China, 2015 // CA Cancer J. Clin. 2016. Vol. 66. P. 115-132. DOI: 10.3322/caac.21338.Wanqing Chen et al. Cancer statistics in China, 2015 // CA Cancer J. Clin. 2016. Vol. 66. P. 115-132. DOI: 10.3322/caac.21338.Malvezzi M. et al. Global trends and predictions in ovarian cancer mortality // Ann. Oncol. 2016. Vol. 27. P. 20-25. DOI: 10.1093/annonc/mdw306.Malvezzi M. et al. Global trends and predictions in ovarian cancer mortality // Ann. Oncol. 2016. Vol. 27. P. 20-25. DOI: 10.1093/annonc/mdw306.Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2015 году. -М.: МНИОИ им. П.А. Герцена. 2017.Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2015 году. -М.: МНИОИ им. П.А. Герцена. 2017.Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи в России в 2016 году. -М.: МНИОИ им. П.А. Герцена. 2017.Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи в России в 2016 году. -М.: МНИОИ им. П.А. Герцена. 2017.Reid B.M., Permuth J.B., Sellers T.A. Epidemiology of ovarian cancer: a review // Cancer Biol. Med. 2017. Vol. 14. P 9-32. DOI: 10.20892/j.issn.2095-3941.2016.0084 FL, USA.Reid B.M., Permuth J.B., Sellers T.A. Epidemiology of ovarian cancer: a review // Cancer Biol. Med. 2017. Vol. 14. P 9-32. DOI: 10.20892/j.issn.2095-3941.2016.0084 FL, USA.Kroeger P.T., Drapkin R. Jr. Pathogenesis and heterogeneity of ovarian cancer // Curr. Opin. Obstet. Gynecol. 2017 Feb. Vol. 29. P. 26-34. DOI: 10.1097/GCO.0000000340.Kroeger P.T., Drapkin R. Jr. Pathogenesis and heterogeneity of ovarian cancer // Curr. Opin. Obstet. Gynecol. 2017 Feb. Vol. 29. P. 26-34. DOI: 10.1097/GCO.0000000340.Ожиганова И.Н. Морфология рака яичников в классификации ВОЗ 2013 года // Практическая онкология. 2014. Т. 15. № 4. C. 143-152.Ожиганова И.Н. Морфология рака яичников в классификации ВОЗ 2013 года // Практическая онкология. 2014. Т. 15. № 4. C. 143-152.Safadi S. et al. Ovarian carcinoma with isolated spinal cord metastasis // J. Invest. Med. High Impact Case Reports. 2016. P 1-3. DOI: 10.1177/2324709616657644.Safadi S. et al. Ovarian carcinoma with isolated spinal cord metastasis // J. Invest. Med. High Impact Case Reports. 2016. P 1-3. DOI: 10.1177/2324709616657644.Гаспаров А.С., Жордания К.И., Паяниди Ю.Г., Ду-бинская Е.Д. Онкологические аспекты кистозных образований яичников // Вестник РАМН. 2013. № 8. C. 44-51.Гаспаров А.С., Жордания К.И., Паяниди Ю.Г., Ду-бинская Е.Д. Онкологические аспекты кистозных образований яичников // Вестник РАМН. 2013. № 8. C. 44-51.Berek J.S., Christopher C., Friedlander M. Cancer of the ovary, fallopian tube and peritoneum FIGO Cancer Report // Intern. J. Gynecol. Obstetrics. 2015. Vol. 131. P. 11-22. DOI: 10.1016/j.ijgo.2015.06.007.Berek J.S., Christopher C., Friedlander M. Cancer of the ovary, fallopian tube and peritoneum FIGO Cancer Report // Intern. J. Gynecol. Obstetrics. 2015. Vol. 131. P. 11-22. DOI: 10.1016/j.ijgo.2015.06.007.Тюляндин С.А. и соавт. Практическая рекомендация по лекарственному лечению рака яичников первичного рака брюшины и рак маточной трубы // Практические рекомендации RUSSCO. 2017. T. 7. № 3. s2. C. 135-145.Тюляндин С.А. и соавт. Практическая рекомендация по лекарственному лечению рака яичников первичного рака брюшины и рак маточной трубы // Практические рекомендации RUSSCO. 2017. T. 7. № 3. s2. C. 135-145.Kurman R.J. et al. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory // Amer. J. Surg Pathol. 2010. Vol. 34. P 433-443. DOI: 10.1097/PAS.0b013e3181cf3d79.Kurman R.J. et al. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory // Amer. J. Surg Pathol. 2010. Vol. 34. P 433-443. DOI: 10.1097/PAS.0b013e3181cf3d79.Vergote I., Trope C.G., Amant F. et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer // N. Engl. J. Med. 2010. Vol. 363. P. 943953. DOI: 10.1056/NEJMoa0908806.Vergote I., Trope C.G., Amant F. et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer // N. Engl. J. Med. 2010. Vol. 363. P. 943953. DOI: 10.1056/NEJMoa0908806.Trimbos J.B. et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma // J. Natl. Cancer Inst. 2003. Vol. 95. P. 105-112.Trimbos J.B. et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma // J. Natl. Cancer Inst. 2003. Vol. 95. P. 105-112.Bast R.C. Jr. et al. New tumor markers: CA-125 and beyond // Int. J. Gynecol. Cancer. 2005. Vol. 15. P. 274281. PMID: 16343244.Bast R.C. Jr. et al. New tumor markers: CA-125 and beyond // Int. J. Gynecol. Cancer. 2005. Vol. 15. P. 274281. PMID: 16343244.Fang Wang et al. CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery // J. Ovarian. Res. 2013. Vol. 6. P. 14-22. DOI: 10.1186/1757-2215-6-14.Fang Wang et al. CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery // J. Ovarian. Res. 2013. Vol. 6. P. 14-22. DOI: 10.1186/1757-2215-6-14.Chi D.S., Venkatraman E.S., Masson V, Hoskins W.J. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma // Gynecol. Oncol. 2012. Vol. 77. № 2. P. 227-238. PMID: 10785469.Chi D.S., Venkatraman E.S., Masson V, Hoskins W.J. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma // Gynecol. Oncol. 2012. Vol. 77. № 2. P. 227-238. PMID: 10785469.Rustin G.J., van der Burg M.E., Griffin C.L. et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomized trial // Lancet. 2010. Vol. 376. № 9747. P. 1155-1163.Rustin G.J., van der Burg M.E., Griffin C.L. et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomized trial // Lancet. 2010. Vol. 376. № 9747. P. 1155-1163.Bairey O. et al. Serum CA-125 as a prognostic factor in non-Hodgkin’s lymphoma // Leuk. Lymphoma. 2003. Vol. 44. P 1733-1738. DOI: 10.1080/104281903100010 4079.Bairey O. et al. Serum CA-125 as a prognostic factor in non-Hodgkin’s lymphoma // Leuk. Lymphoma. 2003. Vol. 44. P 1733-1738. DOI: 10.1080/104281903100010 4079.Чекалова М.А. Ультразвуковая диагностика рака яичников // В кн.: «Современные экспериментальные и клинические подходы к диагностике и рациональному лечению рака яичников». Под ред. В.А. Горбуновой. - М. 2001. С. 47-57.Чекалова М.А. Ультразвуковая диагностика рака яичников // В кн.: «Современные экспериментальные и клинические подходы к диагностике и рациональному лечению рака яичников». Под ред. В.А. Горбуновой. - М. 2001. С. 47-57.Антошечкина М.А., Савинова Е.Б., Чуркина С.О. Использование биомаркеров для ранней диагностики рака яичников // Кремлевская медицина. Клинический вестник. 2011. №4. C. 94-97.Антошечкина М.А., Савинова Е.Б., Чуркина С.О. Использование биомаркеров для ранней диагностики рака яичников // Кремлевская медицина. Клинический вестник. 2011. №4. C. 94-97.Levine D. et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: // Society of Radiologists in Ultrasound Consensus Conference Statement. 2010. Vol. 256. P 943-954. DOI: 10.1148/radiol.10100213.Levine D. et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: // Society of Radiologists in Ultrasound Consensus Conference Statement. 2010. Vol. 256. P 943-954. DOI: 10.1148/radiol.10100213.Kurjak J.K. et al. Transvaginal ultrasound color flow and Doppler waveform of the postmenopausal adnexal mass // Obstet. Gynecol. 1992. Vol. 80. P 917-921.Kurjak J.K. et al. Transvaginal ultrasound color flow and Doppler waveform of the postmenopausal adnexal mass // Obstet. Gynecol. 1992. Vol. 80. P 917-921.Brown D.L. et al. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? // Radiology. 1994. Vol. 190. P 330-336.Brown D.L. et al. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? // Radiology. 1994. Vol. 190. P 330-336.Ferrazzi E. et al. Transvaginal ultrasonographic characterization of ovary a masses: comparison of five scoring systems in a multicenter study // Ultrasound Obstet. Gynecol. 1997. Vol. 10. № 3. P. 192-204.Ferrazzi E. et al. Transvaginal ultrasonographic characterization of ovary a masses: comparison of five scoring systems in a multicenter study // Ultrasound Obstet. Gynecol. 1997. Vol. 10. № 3. P. 192-204.Conway C. et al. Simple cyst in the postmenopausal patient: detection // Book of Abstracts of 7th World Congress on Ultrasound in Obstetrics and Gynecology. Washington. 1997. Vol. 4. P. 97-109.Conway C. et al. Simple cyst in the postmenopausal patient: detection // Book of Abstracts of 7th World Congress on Ultrasound in Obstetrics and Gynecology. Washington. 1997. Vol. 4. P. 97-109.Bagwell D., Bast R.C. Early detection of ovarian cancer // Disease Markers. 2007. Vol. 23. P. 397-410. PMID: 18057523Bagwell D., Bast R.C. Early detection of ovarian cancer // Disease Markers. 2007. Vol. 23. P. 397-410. PMID: 18057523Partridge E. et al. Results from four rounds of ovarian cancer screening in a randomized trial // Obstet. Gynecol. 2009. Vol. 113. P 775-782. DOI: 10.1097/AOG.0b013e31819cda77.Partridge E. et al. Results from four rounds of ovarian cancer screening in a randomized trial // Obstet. Gynecol. 2009. Vol. 113. P 775-782. DOI: 10.1097/AOG.0b013e31819cda77.Stein S.M. et al. Differentiation of benign and malignant adnexal masses: relative value of gray scale, color Doppler, and spectral Doppler sonography // Amer. J. Roentgenol. 1995. Vol. 164. No. 2. P. 381-386.Stein S.M. et al. Differentiation of benign and malignant adnexal masses: relative value of gray scale, color Doppler, and spectral Doppler sonography // Amer. J. Roentgenol. 1995. Vol. 164. No. 2. P. 381-386.Suidan R.S. et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer // Gynecol. Oncol. Author manuscript. Available in: PMC 2015. Vol. 134. P. 455-461. DOI: /10.1016/j.ygyno.2014.07.002.Suidan R.S. et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer // Gynecol. Oncol. Author manuscript. Available in: PMC 2015. Vol. 134. P. 455-461. DOI: /10.1016/j.ygyno.2014.07.002.Manganaro L. et al. Burkitt’s lymphoma presented as advanced ovarian cancer without evidence of lymphadenopathy CT and MRI endings // Case Rep. Radiol. 2013. Vol. 2013. P. 1-5. DOI: 10.1155/2013/940160.Manganaro L. et al. Burkitt’s lymphoma presented as advanced ovarian cancer without evidence of lymphadenopathy CT and MRI endings // Case Rep. Radiol. 2013. Vol. 2013. P. 1-5. DOI: 10.1155/2013/940160.Hyun-Jung Kim et al. The value of diffusion-weighted imaging in the differential diagnosis of ovarian lesions: a meta-analysis // Published online 2016. Vol. 11. № 2. P. 149-165. DOI: 10.1371/journal.pone.0149465.Hyun-Jung Kim et al. The value of diffusion-weighted imaging in the differential diagnosis of ovarian lesions: a meta-analysis // Published online 2016. Vol. 11. № 2. P. 149-165. DOI: 10.1371/journal.pone.0149465.He Zhang et al. Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusion-weighted imaging // J. Ovarian Res. Published online 2012. Vol. 5. P. 33-45. DOI: 10.1186/1757-2215-5-33.He Zhang et al. Evaluation of primary adnexal masses by 3T MRI: categorization with conventional MR imaging and diffusion-weighted imaging // J. Ovarian Res. Published online 2012. Vol. 5. P. 33-45. DOI: 10.1186/1757-2215-5-33.Bekiesinska-Figatowska M. et al. Magnetic resonance imaging as a diagnostic tool in case of ovarian masses in girls and young women // Med. Sci. Monit. 2007. Vol. 13. № 1. P. 116-120.Bekiesinska-Figatowska M. et al. Magnetic resonance imaging as a diagnostic tool in case of ovarian masses in girls and young women // Med. Sci. Monit. 2007. Vol. 13. № 1. P. 116-120.Thomassin-Naggara I. et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses // Published online European Society of Radiology. 2009. Vol. 19. P. 1544-1552. DoI: 10.1007/s00330-009-1299-4.Thomassin-Naggara I. et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses // Published online European Society of Radiology. 2009. Vol. 19. P. 1544-1552. DoI: 10.1007/s00330-009-1299-4.Wessam M.E. et al. Diffusion-weighted magnetic resonance imaging in the assessment of ovarian masses with suspicious features // Strengths and Challenges. 2015. Vol. 46. P. 1279-1289.Wessam M.E. et al. Diffusion-weighted magnetic resonance imaging in the assessment of ovarian masses with suspicious features // Strengths and Challenges. 2015. Vol. 46. P. 1279-1289.Fan X. et al. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors // Int. J. Clin. Exp. Med. 2015. Vol. 8. P. 19928-19937.Fan X. et al. Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors // Int. J. Clin. Exp. Med. 2015. Vol. 8. P. 19928-19937.Bazot M. et al. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: A review // J. Comput. Ass. Tomography. 2008. Vol. 32. P 712-723. DOI: 10.1097/RCT.0b013e31815881ef.Bazot M. et al. Value of magnetic resonance imaging for the diagnosis of ovarian tumors: A review // J. Comput. Ass. Tomography. 2008. Vol. 32. P 712-723. DOI: 10.1097/RCT.0b013e31815881ef.Forstner R. et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update // Europ. Radiol. 2017. Vol. 27. P. 22482257.Forstner R. et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update // Europ. Radiol. 2017. Vol. 27. P. 22482257.Thomassin-Naggara I. et al. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors // J. Magn. Reson. Imaging. 2008. Vol. 28. P. 111-120.Thomassin-Naggara I. et al. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors // J. Magn. Reson. Imaging. 2008. Vol. 28. P. 111-120.Hai-Ming Li et al. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors // Published online 2017. Vol. 10. P. 1-7. DOI: 10.1186/s13048-017-0302-y.Hai-Ming Li et al. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors // Published online 2017. Vol. 10. P. 1-7. DOI: 10.1186/s13048-017-0302-y.Kim M.Y. et al. MR imaging findings of hydrosalpinx: a comprehensive review // Radiographics. 2009. Vol. 29. P. 495-507. DOI: 10.1148/rg.292085070.Kim M.Y. et al. MR imaging findings of hydrosalpinx: a comprehensive review // Radiographics. 2009. Vol. 29. P. 495-507. DOI: 10.1148/rg.292085070.Pretorius E.S. et al. Magnetic resonance imaging of the ovary // Top Magn. Reson. Imaging. 2001. Vol. 12. P. 131-146.Pretorius E.S. et al. Magnetic resonance imaging of the ovary // Top Magn. Reson. Imaging. 2001. Vol. 12. P. 131-146.Wasnik A.P et al. Multimodality imaging of ovarian cystic lesions: review with an imaging based algorithmic approach // World J. Radiol. 2013. Vol. 28. P 113-125. DOI: 10.4329/wjr.v5.i3.113.Wasnik A.P et al. Multimodality imaging of ovarian cystic lesions: review with an imaging based algorithmic approach // World J. Radiol. 2013. Vol. 28. P 113-125. DOI: 10.4329/wjr.v5.i3.113.Bent C.L. et al. MRI appearances of borderline ovarian tumors // Clin. Radiol. 2009. Vol. 64. P. 430-438.Bent C.L. et al. MRI appearances of borderline ovarian tumors // Clin. Radiol. 2009. Vol. 64. P. 430-438.Skirnisdottir I. et al. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer // Int. J. Cancer 2008. Vol. 123. P. 1897-1901.Skirnisdottir I. et al. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer // Int. J. Cancer 2008. Vol. 123. P. 1897-1901.Outwater E.K., Wagner B.J., Mannion C. et al. Sex cord stromal and steroid cell tumors of the ovary // Radio Graphics. 1998. Vol. 18. P. 1523-1546.Outwater E.K., Wagner B.J., Mannion C. et al. Sex cord stromal and steroid cell tumors of the ovary // Radio Graphics. 1998. Vol. 18. P. 1523-1546.Siegelman E.S., Oliver E.R. MR imaging of endometriosis: ten imaging pearls // Radio Graphics. 2012. Vol. 32. P. 1675-1691. DOI: 10.1148/rg.326125518.Siegelman E.S., Oliver E.R. MR imaging of endometriosis: ten imaging pearls // Radio Graphics. 2012. Vol. 32. P. 1675-1691. DOI: 10.1148/rg.326125518.Brown D.L. et al. Primary versus secondary ovarian malignancy imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study // Radiology. 2001. Vol. 219. P. 213-218.Brown D.L. et al. Primary versus secondary ovarian malignancy imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study // Radiology. 2001. Vol. 219. P. 213-218.Foti P. V. et al. MR imaging of ovarian masses: classification and differential diagnosis // Insights Imaging. 2016. Vol. 7. P. 21-41. DOI: 10.1007/s13244-015-0455-4.Foti P. V. et al. MR imaging of ovarian masses: classification and differential diagnosis // Insights Imaging. 2016. Vol. 7. P. 21-41. DOI: 10.1007/s13244-015-0455-4.Yamashita Y. et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications // Radiology. 1993. Vol. 189. P. 721-725. DOI: 10.1148/radiology.189.3.8234695.Yamashita Y. et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications // Radiology. 1993. Vol. 189. P. 721-725. DOI: 10.1148/radiology.189.3.8234695.Болдогоева И.М. Возможности диагностики продолженного роста и рецидивов рака яичников // Уральский мед. журнал. 2009. № 3. C. 78-84.Болдогоева И.М. Возможности диагностики продолженного роста и рецидивов рака яичников // Уральский мед. журнал. 2009. № 3. C. 78-84.Paik E.S. et al. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer // J. Gynecol. Oncol. 2016. Vol. 27. P. 46-52. DOI: 10.3802/jgo.2016.27.e46.Paik E.S. et al. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer // J. Gynecol. Oncol. 2016. Vol. 27. P. 46-52. DOI: 10.3802/jgo.2016.27.e46.Michielsen K.L. et al. Whole body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study // Brit. J. Radiol. 2016. Vol. 89 P. 1067-1078.Michielsen K.L. et al. Whole body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study // Brit. J. Radiol. 2016. Vol. 89 P. 1067-1078.Iyer V.R., Lee S.I. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization // Amer. J. Roentgenol. 2010. Vol. 194. P. 311-321. DOI: 10.2214/AJR.09.3522.Iyer V.R., Lee S.I. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization // Amer. J. Roentgenol. 2010. Vol. 194. P. 311-321. DOI: 10.2214/AJR.09.3522.Rieber A. et al. Preoperative diagnosis of ovarian tumors with MR imaging comparison with transvaginal sonography, positron emission tomography, and histologic findings // Amer. J. Roentgenol. 2001. Vol. 177. P. 123-129. DOI: 10.2214/ajr.177.1.1770123.Rieber A. et al. Preoperative diagnosis of ovarian tumors with MR imaging comparison with transvaginal sonography, positron emission tomography, and histologic findings // Amer. J. Roentgenol. 2001. Vol. 177. P. 123-129. DOI: 10.2214/ajr.177.1.1770123.Cottrill H.M. et al. Positron emission tomography in a premenopausal asymptomatic woman: a case report of increased ovarian uptake in a benign condition // Int. J. Gynecol. Cancer. 2005. Vol. 15. P. 1127-1130. DOI: 10.1136/ijgc-00009577-200511000-00020.Cottrill H.M. et al. Positron emission tomography in a premenopausal asymptomatic woman: a case report of increased ovarian uptake in a benign condition // Int. J. Gynecol. Cancer. 2005. Vol. 15. P. 1127-1130. DOI: 10.1136/ijgc-00009577-200511000-00020.Nowosinska E. et al. FDG-PET/CT as a molecular biomarker in ovarian cancer // Cancer Biomark. 20102011. Vol. 8. P. 167-175. DOI: 10.1155/2012/709049.Nowosinska E. et al. FDG-PET/CT as a molecular biomarker in ovarian cancer // Cancer Biomark. 20102011. Vol. 8. P. 167-175. DOI: 10.1155/2012/709049.

The authors declare that there are no conflicts of interest present.